In vitro permeation of micronized and nanonized alaptide from semisolid formulations

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Opatrilova, Radka ^a   Cernikova, Aneta ^a   Coufalova, Lenka ^a   Dohnal, Jiri ^a   Jampilek, Josef ^a  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(ALANINE (1 AMINO 1 CYCLOPENTANE)CARBONYL); CYCLO(ALANINE-(1-AMINO-1-CYCLOPENTANE)CARBONYL); CYCLOPEPTIDE; NANOPARTICLE; NEUROPEPTIDE;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; ARTIFICIAL SKIN; CHEMISTRY; PERMEABILITY; SKIN; SWINE;

ANIMALS; MEMBRANES, ARTIFICIAL; NANOPARTICLES; NEUROPEPTIDES; PEPTIDES, CYCLIC; PERMEABILITY; SKIN; SKIN, ARTIFICIAL; SWINE;

EID: 84893847515     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/787283     Document Type: Article

References (45)

1. De Souza Russo E. M., Russo V. F. T.,. Inventors; Cristalia Produtos Quimicos e Farmaceuticos, Ltd., assignee, "Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries" WO 2002083086 A1, 2002
2. Hashimoto K., Nakata K., Sakanaka M., Tanaka J.,. Inventors; Japan Science and Technology Corporation, assignee, "Skin tissue regeneration promoters comprising ginsenoside Rb1" EP1295893 A1, 2003
3. Choi S. G., Baek E. J., Davaa E., Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam. International Journal of Pharmaceutics 2013 447 102 108
4. Kasafirek E., Sturc A., Roubalova A., Linear tri- and tetrapeptides acting as prodrugs. Collection of Czechoslovak Chemical Communications 1992 57 179 187
5. Kasafirek E., Rybak M., Krejci I., Sturc A., Krepela E., Sedo A., Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. Life Sciences 1992 50 3 187 193 2-s2.0-0026508890 10.1016/0024-3205(92)90271-P
6. Celis M. E., Taleisnik S., Walter R., Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte- stimulating hormone. Proceedings of the National Academy of Sciences of the United States of America 1971 68 7 1428 1433 2-s2.0-0015093326
7. Petersson M., Uvnäs-Moberg K., Prolyl-leucyl-glycinamide shares some effects with oxytocin but decreases oxytocin levels. Physiology and Behavior 2004 83 3 475 481 2-s2.0-9744248711 10.1016/j.physbeh.2004.08.034 (Pubitemid 39586670)
8. Radl S., Kasafirek E., Krejci I., Alaptide. Drugs of the Future 1990 15 445 447
9. Jampílek J., Opatrilova R., Rezacova A., Oktabec Z., Dohnal J.,. Inventors; Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, assignee, "Alaptide: Methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and veterinary applications" PTC/CZ2012/000074, 2012
10. Douša M., Lemr K., Liquid chromatographic method for enantiopurity control of alaptide using polysaccharide stationary phases. Journal of Separation Science 2011 34 12 1402 1406 2-s2.0-79959231140 10.1002/jssc. 201100135
11. Maixner J., Rohlíček J., Kratochvíl B., Šturc A., X-ray powder diffraction data for alaptide, 8(S)-methyl-6,9-diazaspiro/4,5/ decane-7,10-dione or cyclo(l-alanyl-1-amino-1-cyclopentan carbonyl), cyclo(l-Ala-Acp). Powder Diffraction 2009 24 32 34 2-s2.0-69549113358
12. Julinek O., Setnicka V., Rezacova A., Dohnal J., Vosatka V., Urbanova M., Product of alaptide synthesis: determination of the absolute configuration. Journal of Pharmaceutical and Biomedical Analysis 2010 53 958 961
13. Burns T., Breathnach S., Cox N., Griffiths C., Rook's Textbook of Dermatology 2004 7th Oxford, UK Blackwell Publishing
14. James W., Berger T., Elston D., Andrews' Diseases of the Skin: Clinical Dermatology 2006 10th Philadelphia, PA, USA Saunders
15. Watt F. M., The epidermal keratinocyte. BioEssays 1988 8 5 163 167 2-s2.0-0024005907
16. Vanzura J., Kosar K., Kasafirek E., Inhibition of proliferative activity by cyclic dipeptides: spirocyclic derivatives of 1-aminocyclopentanecarboxylic acid. Toxicology Letters 1986 31 3 189 193 2-s2.0-0022656905 (Pubitemid 16098315)
17. Lapka R., Pharmacokinetics and brain entry of alaptide, a novel nootropic agent, in mice, rats and rabbits. Journal of Pharmacy and Pharmacology 1991 43 12 874 876 2-s2.0-0026042950
18. Kosar K., Vanzura J., Embryotoxicity of L-prolyl-L-leucyl-glycinamide, cyclo(1-amino-cyclopentanecarbonyl-alanyl) and cyclo(glycyl-leucyl), new potential neuropeptides in chick embryos. Pharmazie 1988 43 10 715 716 2-s2.0-0023716854 (Pubitemid 18260308)
19. Bioveta-Alaptid veterinary ointment.cz, http://www.bioveta.cz/en/ veterinary-division/products/new-products-for-dogs-and-cats/alaptid-veterinary- ointment.html
20. Schneider M., Stracke F., Hansen S., Schaefer U. F., Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 2009 1 197 206
21. Baroli B., Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? Journal of Pharmaceutical Sciences 2010 99 1 21 50 2-s2.0-73949137818 10.1002/jps.21817
22. Prow T. W., Grice J. E., Lin L. L., Faye R., Butler M., Becker W., Wurm E. M. T., Yoong C., Robertson T. A., Soyer H. P., Roberts M. S., Nanoparticles and microparticles for skin drug delivery. Advanced Drug Delivery Reviews 2011 63 6 470 491 2-s2.0-79953198946 10.1016/j.addr.2011.01.012
23. Campbell C. S. J., Contreras-Rojas L. R., Delgado-Charro M. B., Guy R. H., Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. Journal of Controlled Release 2012 162 201 207
24. Kimura E., Kawano Y., Todo H., Ikarashi Y., Sugibayashi K., Measurement of skin permeation/penetration of nanoparticles for their safety evaluation. Biological & Pharmaceutical Bulletin 2012 35 1476 1486
25. Kansy M., Senner F., Gubernator K., Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. Journal of Medicinal Chemistry 1998 41 7 1007 1010 2-s2.0-0032568397 10.1021/jm970530e (Pubitemid 28207375)
26. Avdeef A., Tsinman O., PAMPA-a drug absorption in vitro model: 13. Chemical selectivity due to membrane hydrogen bonding: in combo comparisons of HDM-, DOPC-, and DS-PAMPA models. European Journal of Pharmaceutical Sciences 2006 28 1-2 43 50 2-s2.0-33644895433 10.1016/j.ejps.2005.12.008
27. Tam K. Y., Velicky M., Dryfe R. A. W., Mandic Z., The importance of and different approaches to permeability determination. Physico-Chemical Methods in Drug Discovery and Development 2012 Zagreb, Croatia IAPC 121 164
28. Franz T. J., Percutaneous absorption. On the relevance of in vitro data. Journal of Investigative Dermatology 1975 64 3 190 195 2-s2.0-0016610679
29. Jampilek J., Brychtova K., Azone analogues: classification, design, and transdermal penetration principles. Medical Research Review 2012 32 907 947
30. Jampilek J., Transdermal application of drugs and techniques affecting skin barrier. Journal of Bioequivalence & Bioavailability 2013 5 233 235
31. Jacobi U., Kaiser M., Toll R., Mangelsdorf S., Audring H., Otberg N., Sterry W., Lademann J., Porcine ear skin: an in vitro model for human skin. Skin Research and Technology 2007 13 1 19 24 2-s2.0-33846503970 10.1111/j.1600-0846. 2006.00179.x (Pubitemid 46152448)
32. Herkenne C., Naik A., Kalia Y. N., Hadgraft J., Guy R. H., Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharmaceutical Research 2006 23 8 1850 1856 2-s2.0-33746921312 10.1007/s11095-006-9011-8 (Pubitemid 44200549)
33. Meyer W., Schwarz R., Neurand K., The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Current Problems in Dermatology 1978 7 39 52 2-s2.0-0018228183
34. Wu H., Ramachandran C., Weiner N. D., Roessler B. J., Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. International Journal of Pharmaceutics 2001 220 1-2 63 75 2-s2.0-0035806281 10.1016/S0378-5173(01) 00671-8 (Pubitemid 32476842)
35. Akhtar N., Rehman M. U., Khan H. M. S., Rasool F., Saeed T., Murtaza G., Penetration enhancing effect of polysorbate 20 and 80 on the in vitro percutaneous absorption of L-ascorbic acid. Tropical Journal of Pharmaceutical Research 2011 10 3 281 288 2-s2.0-79959990575 10.4314/tjpr.v10i3.1
36. Panigrahi L., Pattnaik S., Ghosal S. K., The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins. AAPS PharmSciTech 2005 6 2 E167 E173 2-s2.0-27744519546 10.1208/pt060225 (Pubitemid 41631756)
37. Huang C. T., Tsai M. J., Lin Y. H., Effect of microemulsions on transdermal delivery of citalopram: optimization studies using mixture design and response surface methodology. International Journal of Nanomedicine 2013 2013 2295 2304
38. Rhee Y.-S., Choi J.-G., Park E.-S., Chi S.-C., Transdermal delivery of ketoprofen using microemulsions. International Journal of Pharmaceutics 2001 228 1-2 161 170 2-s2.0-0035834177 10.1016/S0378-5173(01)00827-4 (Pubitemid 32905375)
39. Kennish L., Reidenberg B., A review of the effect of occlusive dressings on lamellar bodies in the stratum corneum and relevance to transdermal absorption. Dermatology Online Journal 2005 11 3 7 2-s2.0-33746792072
40. Bhushan B., Handbook of Nanotechnology 2004 Berlin, Germany Springer
41. Buzea C., Pacheco I. I., Robbie K., Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2007 2 MR17 MR71
42. Corredor E., Testillano P. S., Coronado M.-J., González-Melendi P., Fernández-Pacheco R., Marquina C., Ibarra M. R., De La Fuente J. M., Rubiales D., Pérez-De-Luque A., Risuo M.-C., Nanoparticle penetration and transport in living pumpkin plants: in situ subcellular identification. BMC Plant Biology 2009 9, article 45 2-s2.0-65649130052 10.1186/1471-2229-9-45
43. Verma A., Stellacci F., Effect of surface properties on nanoparticle-cell interactions. Small 2010 6 1 12 21 2-s2.0-73949087550 10.1002/smll.200901158
44. Watkinson A. C., Bunge A. L., Hadgraft J., Lane M. E., Nanoparticles do not penetrate human skin-a theoretical perspective. Pharmaceutical Research 2013 30 1943 1946
45. Barratt M. D., Quantitative structure-activity relationships for skin permeability. Toxicology in Vitro 1995 9 1 27 37 2-s2.0-0028898732 10.1016/0887-2333(94)00190-6